Works matching IS 17528054 AND DT 2022 AND VI 15 AND IP 11
Results: 20
Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2772, doi. 10.1111/cts.13404
- By:
- Publication type:
- Article
Human radiolabeled mass balance studies supporting the FDA approval of new drugs.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2567, doi. 10.1111/cts.13403
- By:
- Publication type:
- Article
Glucocorticoids mediate transcriptome‐wide alternative polyadenylation: Potential mechanistic and clinical implications.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2758, doi. 10.1111/cts.13402
- By:
- Publication type:
- Article
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2744, doi. 10.1111/cts.13401
- By:
- Publication type:
- Article
Effects of genotype and food on naltrexone exposure in adolescents.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2732, doi. 10.1111/cts.13399
- By:
- Publication type:
- Article
Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2720, doi. 10.1111/cts.13398
- By:
- Publication type:
- Article
Savor the flavor: A randomized double‐blind study assessing taste‐enhanced placebo analgesia in healthy volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2709, doi. 10.1111/cts.13397
- By:
- Publication type:
- Article
A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2697, doi. 10.1111/cts.13395
- By:
- Publication type:
- Article
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2685, doi. 10.1111/cts.13394
- By:
- Publication type:
- Article
An untargeted metabolomics analysis of exogenous chemicals in human milk and transfer to the infant.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2576, doi. 10.1111/cts.13393
- By:
- Publication type:
- Article
The safety and tolerability of levodopa eye drops for the treatment of ocular disorders: A randomized first‐in‐human study.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2673, doi. 10.1111/cts.13392
- By:
- Publication type:
- Article
An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2663, doi. 10.1111/cts.13391
- By:
- Publication type:
- Article
Advancing translational science education.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2555, doi. 10.1111/cts.13390
- By:
- Publication type:
- Article
Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2652, doi. 10.1111/cts.13389
- By:
- Publication type:
- Article
Genomewide association study identifies a novel variant associated with tacrolimus trough concentration in Chinese renal transplant recipients.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2640, doi. 10.1111/cts.13388
- By:
- Publication type:
- Article
Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2625, doi. 10.1111/cts.13387
- By:
- Publication type:
- Article
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2613, doi. 10.1111/cts.13386
- By:
- Publication type:
- Article
Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2597, doi. 10.1111/cts.13372
- By:
- Publication type:
- Article
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2583, doi. 10.1111/cts.13362
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2551, doi. 10.1111/cts.13140
- Publication type:
- Article